Literature DB >> 1313802

Mechanism of Ca2+ inhibition of inositol 1,4,5-trisphosphate (InsP3) binding to the cerebellar InsP3 receptor.

G A Mignery1, P A Johnston, T C Südhof.   

Abstract

Ca2+ efficiently inhibits binding of inositol 1,4,5-trisphosphate (InsP3) to the InsP3 receptor in cerebellar membranes but not to the purified receptor. We have now investigated the mechanism of action by which Ca2+ inhibits InsP3 binding. Our results suggest that Ca2+ does not cause the stable association of a Ca(2+)-binding protein with the receptor. Instead, Ca2+ leads to the production of a soluble, heat-stable, low molecular weight substance from cerebellar membranes that competes with InsP3 for binding. This inhibitory substance probably represents endogenously generated InsP3 as judged by the fact that it co-purifies with InsP3 on anion-exchange chromatography, competes with [3H]InsP3 binding in a pattern similar to unlabeled InsP3, and is in itself capable of releasing 45Ca2+ from permeabilized cells. A potent Ca(2+)-activated phospholipase C activity producing InsP3 was found in cerebellar microsomes that exhibited a Ca2+ dependence identical to the Ca(2+)-dependent inhibition of InsP3 binding. Together these results suggest that the Ca(2+)-dependent inhibition of InsP3 binding to the cerebellar receptor is due to activation of a Ca(2+)-sensitive phospholipase C enriched in cerebellum. Nevertheless, Ca2+ probably also modulates the InsP3 receptor function by a direct interaction with the receptor that does not affect InsP3 binding but regulates InsP3-dependent channel gating.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1313802

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  35 in total

1.  Single-channel function of recombinant type 2 inositol 1,4, 5-trisphosphate receptor.

Authors:  J Ramos-Franco; D Bare; S Caenepeel; A Nani; M Fill; G Mignery
Journal:  Biophys J       Date:  2000-09       Impact factor: 4.033

2.  Carbonic anhydrase-related protein is a novel binding protein for inositol 1,4,5-trisphosphate receptor type 1.

Authors:  Junji Hirota; Hideaki Ando; Kozo Hamada; Katsuhiko Mikoshiba
Journal:  Biochem J       Date:  2003-06-01       Impact factor: 3.857

3.  Integrated luminal and cytosolic aspects of the calcium release control.

Authors:  Irina Baran
Journal:  Biophys J       Date:  2003-03       Impact factor: 4.033

4.  Functional and biochemical analysis of the type 1 inositol (1,4,5)-trisphosphate receptor calcium sensor.

Authors:  Huiping Tu; Elena Nosyreva; Tomoya Miyakawa; Zhengnan Wang; Akiko Mizushima; Masamitsu Iino; Ilya Bezprozvanny
Journal:  Biophys J       Date:  2003-07       Impact factor: 4.033

5.  A biophysical model of synaptic delay learning and temporal pattern recognition in a cerebellar Purkinje cell.

Authors:  Volker Steuber; David Willshaw
Journal:  J Comput Neurosci       Date:  2004 Sep-Oct       Impact factor: 1.621

6.  Gating mechanisms of the type-1 inositol trisphosphate receptor.

Authors:  Irina Baran
Journal:  Biophys J       Date:  2005-05-20       Impact factor: 4.033

7.  Metabotropic glutamate receptor activation in cerebellar Purkinje cells as substrate for adaptive timing of the classically conditioned eye-blink response.

Authors:  J C Fiala; S Grossberg; D Bullock
Journal:  J Neurosci       Date:  1996-06-01       Impact factor: 6.167

8.  Isoform-specific function of single inositol 1,4,5-trisphosphate receptor channels.

Authors:  J Ramos-Franco; M Fill; G A Mignery
Journal:  Biophys J       Date:  1998-08       Impact factor: 4.033

9.  Single channel function of recombinant type-1 inositol 1,4,5-trisphosphate receptor ligand binding domain splice variants.

Authors:  J Ramos-Franco; S Caenepeel; M Fill; G Mignery
Journal:  Biophys J       Date:  1998-12       Impact factor: 4.033

10.  Micromolar calcium decreases affinity of inositol trisphosphate receptor in vascular smooth muscle.

Authors:  D Benevolensky; I I Moraru; J Watras
Journal:  Biochem J       Date:  1994-05-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.